Depression comorbid with tuberculosis and its impact on health status: cross-sectional analysis of community-based data from 48 low- and middle-income countries by Koyanagi, Ai et al.
RESEARCH ARTICLE Open Access
Depression comorbid with tuberculosis and
its impact on health status: cross-sectional
analysis of community-based data from 48
low- and middle-income countries
Ai Koyanagi1,2* , Davy Vancampfort3,4, André F. Carvalho5, Jordan E. DeVylder6, Josep Maria Haro1,2,
Damiano Pizzol7, Nicola Veronese8,9 and Brendon Stubbs10,11,12
Abstract
Background: Depression in tuberculosis increases the risk for adverse health outcomes. However, little is known
about comorbid depression and tuberculosis in the general population. Thus, we assessed the association between
depression and tuberculosis, and the decrements in health status associated with this comorbidity in 48 low- and
middle-income countries.
Methods: Cross-sectional, community-based data from the World Health Survey on 242,952 individuals aged≥ 18 years
were analyzed. Based on the World Mental Health Survey version of the Composite International Diagnostic Interview,
past 12-month depression was categorized into depressive episode, brief depressive episode, subsyndromal depression,
and no depression. Health status across six domains (cognition, interpersonal activities, sleep/energy, self-care, mobility,
pain/discomfort) was assessed. Multivariable logistic and linear regression analyses were performed to assess the
associations.
Results: The prevalence of depressive episode among those with and without tuberculosis was 23.7% and 6.8%,
respectively (P < 0.001). Tuberculosis was associated with a 1.98 (95% CI 1.47–2.67), 1.75 (95% CI 1.26–2.42), and 3.68
(95% CI 3.01–4.50) times higher odds for subsyndromal depression, brief depressive episode, and depressive episode,
respectively. Depressive episode co-occurring with tuberculosis was associated with significantly worse health status
across all six domains compared to tuberculosis alone. Interaction analysis showed that depression significantly
amplifies the association between TB and difficulties in self-care but not in other health domains.
Conclusions: Depression is highly prevalent in adults with tuberculosis, and is associated with worse health status
compared to tuberculosis without depression. Public health efforts directed to the recognition and management of
depression in people with tuberculosis may lead to better outcomes.
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Background
Tuberculosis (TB) is one of the top 10 causes of deaths glo-
bally [1]. In 2015, there were 10.4 million new TB cases
and 1.8 million deaths due to TB. Over 95% of TB cases
and deaths occur in developing countries [1]. Depression
often coexists with TB [2], and this comorbidity is associ-
ated with poor adherence to TB treatment and higher
mortality [3]. Lack of adherence to anti-TB regimens may
lead to higher risk for drug resistance, morbidity, and
mortality, as well as community exposure to TB [4, 5].
In low- and middle-income countries (LMICs), the
prevalence of depression is high and may be increasing [6].
A recent large prospective study from Korea found that
depression at baseline is associated with a higher risk for
incident TB [7]. Depression may lead to an increased
susceptibility to TB by compromising immunity or through
neglected self-care [8]. Thus, depression may be an
unrecognized driver of the global TB and multidrug
resistant TB (MDR-TB) epidemics [2]. However, the few
previous studies on the association between depression and
TB from LMICs have only been conducted in clinical
settings with small sample sizes, and information from the
general population is lacking. Furthermore, there is limited
information on the joint effect of TB and depression on
health status. We therefore assessed the association be-
tween TB and depression, and whether the co-occurrence
of TB and depression confers a more pronounced decre-
ment in health status and function compared to TB alone
using community-based, predominantly nationally repre-
sentative data from 48 LMICs that participated in the
World Health Survey (WHS). Epidemiological data on the
TB/depression comorbidity and its effect on health out-
comes are crucial to provide a more accurate assessment of
the public health significance of this comorbidity.
Methods
The survey
The WHS was a cross-sectional survey carried out in 70
countries from 2002 to 2004. Survey details are available
elsewhere (http://www.who.int/healthinfo/survey/en/).
Briefly, single-stage random sampling and stratified
multi-stage random cluster sampling was conducted in
10 and 60 countries, respectively. Eligible participants
were those with a valid home address and aged ≥
18 years. One individual was randomly chosen from the
household with the use of Kish tables. The questionnaire
was subject to standard translation procedures to ensure
comparability between countries. Face-to-face interviews
were conducted by trained interviewers. The overall
individual response rate was 98.5% [9]. To adjust for
non-response, sampling weights were generated using
the population distribution as reported by the United
Nations Statistical Division. Ethical approval for the
survey was provided by ethical boards at each study site.
All participants gave their informed consent.
Variables
TB
Because the WHS did not include mycobacterial culture
or sputum smear examinations, TB was based on past
12-month symptoms of active TB. Specifically, as in pre-
vious WHS publications [10–12], those who had both
(1) a cough that lasted for 3 weeks or longer and (2)
blood in phlegm (or coughed up blood) were considered
to have active TB. Previous studies have shown that the
presence of these typical symptoms are likely to have a
sensitivity and specificity of 65–70% and 55–75%,
respectively, in the detection of TB [10].
Depression
The severity of depressive symptoms was established
based on the individual questions of the World Mental
Health Survey version of the Composite International
Diagnostic Interview, which assessed the duration and
persistence of depressive symptoms in the past
12 months [13]. Following the algorithms used in a pre-
vious WHS publication [14], four mutually exclusive
groups were established based on the ICD-10 Diagnostic
Criteria for Research (ICD-10-DCR) [15], where criter-
ion B referred to symptoms of depressed mood, loss of
interest, and fatigability. The algorithms used to define
the four mutually exclusive groups were the following:
Depressive episode group
At least two criterion B symptoms with a total of at
least four depressive symptoms lasting 2 weeks most
of the day or all of the day.
Brief depressive episode group
Same criteria as depressive episode but did not meet
the 2-week duration criterion.
Subsyndromal depression
At least one criterion B symptom with the total
number of symptoms being three or less. The criteria
of duration of at least 2 weeks and presence of
symptoms during most of the day had to be met.
No depressive disorder group
None of the above.
In some analyses, we also dichotomized this variable
as the absence or presence of depressive episode.
Health status
Health status was assessed with the use of 12 health-
related questions pertaining to six different domains,
namely (1) mobility, (2) pain and discomfort, (3) self-care,
(4) cognition, (5) interpersonal activities, and (6) sleep and
energy. These domains correspond to frequently used
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health outcome measures including the Short Form 12
[16], the Health Utilities Index Mark 3 [17], and the
EuroQol 5D [18], and have been used as indicators of
health status in prior WHS studies [19, 20]. Each domain
consisted of two questions that assessed health function in
the past 30 days. The actual questions can be found in
Additional file 1: Table S1. Each item was scored on a
five-point scale ranging from ‘none’ to ‘extreme/cannot
do’. For each separate domain, we used factor analysis
with polychoric correlations to obtain a factor score which
was later converted to scores ranging from 0 to 100 with
higher values representing worse health function [20].
Control variables
The selection of the control variables were based on past
literature [10]. Sociodemographic variables included age,
sex, education (no formal education, primary education,
secondary or high school completed, or tertiary education
completed), wealth, household size, and setting (rural or
urban). Principal component analysis based on 15–20
assets was conducted to establish country-wise wealth
quintiles. Current smoking was dichotomized as ‘Yes’ and
‘No’. Respondents were asked how many standard drinks
of any alcoholic beverage they had on each day of the past
7 days. Females who reported consuming at least four
drinks, and males who reported consuming at least five
drinks, on 1 or 2 days in the past 7 days were considered
infrequent heavy drinkers, and respondents who drank
these amounts at least 3 days in the past 7 days were
considered frequent heavy drinkers. All other respondents,
apart from lifetime abstainers, were considered non-heavy
drinkers [21, 22]. Body mass index (BMI; kg/m2) was
based on self-reported weight and height, and was catego-
rized as < 18.5 (underweight), 18.5–24.9 (normal weight),
25.0–29.9 (overweight), and ≥ 30 (obese). Diabetes was
based on self-reported diagnosis.
Statistical analysis
Publically available data of the WHS included 69 countries.
The data were nationally representative for all countries with
the exception of China, Comoros, the Republic of Congo,
Ivory Coast, India, and Russia. We excluded 10 countries as
they lacked sampling information. A further 10 high-income
countries were deleted as the focus of the study was on
LMICs. Finally, Turkey was deleted due to lack of informa-
tion on education and diabetes. Thus, a total of 48 countries,
of which 21 (n = 105,286) and 27 (n = 137,666) were low-
income and middle-income countries, respectively, at the
time of the survey (2003) according to the World Bank,
were included in the final sample. According to the United
Nations’ classification system (http://unstats.un.org/unsd/
methods/m49/m49regin.htm), these corresponded to 20
countries in Africa (n = 82,424), 6 in the Americas
(n = 62,732), 13 in Asia (n = 81,633), and 9 in Europe
(n = 16,163). Information on the individual countries
is provided in Additional file 1: Table S2.
Statistical analyses were performed with Stata 14.1
(Stata Corp LP, College station, Texas). Descriptive
analyses included unweighted Ns, and weighted propor-
tions and means.
First, in order to assess the association between TB
(exposure) and depression (subtypes; outcome), we con-
ducted multivariable multinomial logistic regression analyses
using the overall sample. We also assessed the association
between TB (exposure) and depressive episode (outcome)
using multivariable binary logistic regression while stratify-
ing by region (Africa, Americas, Asia, Europe) or country
income level (low-income, middle-income). For these strati-
fied analyses, we could not assess all depression subtypes as
the outcome as the number of individuals withTB was small
in some subsamples.
Next, we created a four-category variable based on the
presence or absence of depressive episode and TB,
namely (1) no depression and no TB (n = 183,455); (2)
depression without TB (n = 11,440); (3) TB without
depression (n = 2617); and (4) TB with depression (n = 687),
to assess whether TB with depression is associated with a
larger decrement in health status as compared with TB
alone. We conducted multivariable linear regression with
this this four-category variable as the exposure and the six
health status variables as the outcomes (mobility, pain/dis-
comfort, self-care, cognition, interpersonal activities, sleep/
energy). We also conducted age-stratified analyses to assess
whether the TB and depressive episode comorbidity have
different effects on health status by age groups. Age was
categorized as 18–44 (young adults; 67.8%), 45–64 (middle-
aged adults; 23.6%), and ≥ 65 (older adults; 8.6%) years,
broadly representing distinct life stages [23]. In order to
assess whether there is effect modification by depressive
episodes in the association between TB and health status,
we also conducted interaction analysis by including an
interaction term in the model using the overall sample
(TB × depressive episode). We did not conduct interaction
analysis by age groups due to the small sample size and
possibility for lack of statistical power.
All regression analyses were adjusted for age, sex, educa-
tion, wealth, household size, location, smoking, alcohol
consumption, BMI, diabetes, and country. Adjustment for
country was performed by including dummy variables in
the models, as in previous WHS publications [11, 19]. All
variables were included in the models as categorical
variables with the exception of age, household size, and the
six variables on health status (continuous variables). The
sample weighting and the complex study design were taken
into account in all analyses. Results from the logistic and
linear regression are presented as odds ratios (ORs) and b-
coefficients, respectively, with 95% confidence intervals
(CIs). The level of statistical significance was set at P < 0.05.
Koyanagi et al. BMC Medicine  (2017) 15:209 Page 3 of 10
Under 10% of the data were missing for the variables
used in the analysis with the exception of TB (17.7%),
BMI (30.3%), and diabetes (12.6%). For the regression
analyses, we conducted multiple imputation of missing
values using the mi commands in Stata using chained
equations (20 imputations) [24]. This method uses infor-
mation from all other variables except the one being
imputed to impute missing values. The variables
included in the imputation model were the outcome and
all other covariates [12]. The results based on complete
case analysis were similar.
Results
The analytical sample consisted of 242,952 individuals
with a mean (SD) age of 38.4 (16.1) years and 50.8%
were women (Table 1). The prevalence (95% CI) of TB
was 1.7% (1.5–1.8%). All types of depression were more
frequent among those with TB, with the difference being
particularly pronounced for depressive episode (Fig. 1).
The prevalence of depressive episode among those with
and without TB was 23.7% (95% CI 20.5–27.1%) and 6.8%
(95% CI 6.5–7.1%), respectively (χ2 test P < 0.001). The
results of the multivariable multinomial logistic regression
using the overall sample showed that TB is associated with
a 1.98 (95% CI 1.47–2.67), 1.75 (95% CI 1.26–2.42), and
3.68 (95% CI 3.01–4.50) times higher odds for subsyndro-
mal depression, brief depressive episode, and depressive
episode, respectively (Table 2). Older age, female sex,
lower levels of wealth, smoking, and diabetes were signifi-
cant correlates of depressive episode.
The association between TB and depressive episode
estimated by multivariable binary logistic regression by
regions or country income levels are shown in Table 3. TB
was associated with a depressive episode across regions and
county income levels although the estimates for Europe did
not reach statistical significance, possibly due to lack of
statistical power (OR, 2.67; 95% CI 0.75–9.52; P = 0.1293).
Compared to those with no TB or depressive episode,
depression alone, TB alone, and comorbid TB/depres-
sion were all significantly associated with worse health
status scores in all domains. Comorbid TB/depression
was associated with the largest decline (Table 4).
The results of the age-stratified analyses are shown
in Additional file 1: Table S3. The decline in health
status associated with depression alone and co-
occurring TB/depression was similar across age
groups, but that of TB alone was less pronounced in
the oldest age group (i.e., ≥ 65 years). In order to
assess whether the difference between TB alone and
comorbid TB/depression is statistically significant, we
also conducted the same analysis but changing the
reference category to TB alone (overall sample). The
b-coefficients (95% CIs) for comorbid TB/depression
(vs. TB alone) were mobility 19.17 (14.52–23.81), self-
care 18.46 (13.41–23.54), pain/discomfort 20.14
(16.23–24.04), cognition 15.61 (11.13-20.09), interper-
sonal activities 15.04 (10.13–19.96), and sleep/energy
19.67 (14.47–24.88) (all P < 0.0001). Overall, the
interaction analysis showed that depression signifi-
cantly amplifies the association between TB and difficul-
ties in self-care but not with other health domains
(Additional file 1: Table S4).
Table 1 Sample characteristics
Characteristic Category Unweighted
N
% or Mean
(SD)
Tuberculosis No 196,417 98.3
Yes 3347 1.7
Depression No depression 205,752 87.7
Subsyndromal
depression
5238 2.6
Brief depressive
episode
6674 2.9
Depressive episode 13,965 6.9
Age, years Mean (SD) 233,879 38.4 (16.1)
Sex Male 104,355 49.2
Female 129,448 50.8
Education No formal 52,116 26.5
Primary 76,193 30.9
Secondary 86,740 33.5
Tertiary 17,860 9.2
Wealth Poorest 51,599 20.1
Poorer 45,893 20.0
Middle 42,317 19.9
Richer 40,128 20.0
Richest 37,724 20.0
Household size Mean (SD) 242,311 5.7 (3.0)
Setting Rural 117,556 56.5
Urban 114,825 43.5
Current smoking No 174,814 73.5
Yes 54,746 26.5
Alcohol
consumption
Lifetime abstainer 142,282 66.4
Non-heavy 74,016 28.8
Infrequent heavy 8817 3.7
Frequent heavy 2411 1.0
Body mass index,
kg/m2
<18.5 16,883 13.8
18.5–24.9 95,208 57.9
25.0–29.9 38,700 19.3
≥30.0 18,287 9.0
Diabetes No 205,671 97.0
Yes 6537 3.0
Data are unweighted N and weighted proportion or mean (SD)
SD standard deviation
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Fig. 1 Prevalence of each type of depression by the presence or absence of tuberculosis. Bars denote 95% confidence intervals. Estimates are
based on weighted sample
Table 2 Association of tuberculosis and other covariates with depression estimated by multivariable multinomial logistic regression
Depression subtypes (Reference = No depression)
Subsyndromal depression Brief depressive episode Depressive episode
Characteristic Category OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value
Tuberculosis Yes vs. No 1.98 (1.47–2.67) <0.0001 1.75 (1.26–2.42) 0.0008 3.68 (3.01–4.50) <0.0001
Age, years Per unit increase 1.02 (1.02–1.03) <0.0001 1.01 (1.00–1.01) 0.0003 1.02 (1.02–1.02) <0.0001
Sex Female vs. Male 1.84 (1.60–2.12) <0.0001 2.19 (1.94–2.46) <0.0001 2.06 (1.87–2.27) <0.0001
Education No formal 1.00 1.00 1.00
Primary 0.86 (0.72–1.03) 0.1101 0.95 (0.82–1.10) 0.4629 0.92 (0.83–1.03) 0.1414
Secondary 0.76 (0.61–0.94) 0.0133 0.98 (0.81–1.18) 0.8148 0.77 (0.67–0.88) 0.0001
Tertiary 0.83 (0.53–1.30) 0.4073 0.80 (0.62–1.02) 0.0686 0.82 (0.53–1.25) 0.3464
Wealth Poorest 1.00 1.00 1.00
Poorer 1.00 (0.80–1.25) 0.9855 0.98 (0.84–1.16) 0.8384 0.95 (0.85–1.07) 0.4023
Middle 1.07 (0.86–1.34) 0.5281 0.90 (0.76–1.06) 0.2022 0.96 (0.84–1.08) 0.4651
Richer 1.05 (0.81–1.36) 0.7289 0.97 (0.82–1.16) 0.7557 0.87 (0.76–1.00) 0.0486
Richest 0.90 (0.64–1.26) 0.5175 0.80 (0.66–0.97) 0.0229 0.69 (0.57–0.83) 0.0001
Household size Per unit increase 1.03 (1.00–1.06) 0.0296 1.01 (0.98–1.03) 0.4946 1.01 (0.99–1.04) 0.2889
Setting Urban vs. Rural 0.93 (0.79–1.11) 0.4373 1.12 (0.98–1.28) 0.0978 1.05 (0.94–1.17) 0.4040
Current smoking Yes vs. No 1.31 (1.10–1.55) 0.0026 1.26 (1.10–1.44) 0.0007 1.29 (1.14–1.45) <0.0001
Alcohol consumption Lifetime abstainer 1.00 1.00 1.00
Non-heavy 1.27 (1.09–1.47) 0.0026 1.51 (1.32–1.73) <0.0001 1.10 (0.99–1.22) 0.0685
Infrequent heavy 1.45 (1.02–2.06) 0.0407 1.72 (1.29–2.28) 0.0002 1.03 (0.83–1.29) 0.7845
Frequent heavy 2.10 (1.15–3.85) 0.0159 1.85 (1.18–2.92) 0.0080 1.14 (0.79–1.65) 0.4887
Body mass index, kg/m2 <18.5 1.02 (0.76–1.36) 0.8991 1.01 (0.83–1.23) 0.8988 1.08 (0.90–1.31) 0.4065
18.5–24.9 1.00 1.00 1.00
25.0–29.9 1.10 (0.89–1.36) 0.3673 0.96 (0.83–1.11) 0.5485 0.99 (0.88–1.11) 0.8586
≥30.0 1.09 (0.84–1.41) 0.5230 1.05 (0.86–1.29) 0.6136 1.05 (0.91–1.22) 0.4831
Diabetes Yes vs. No 1.14 (0.84–1.54) 0.4000 1.39 (1.09–1.76) 0.0076 1.91 (1.62–2.24) <0.0001
Model is adjusted for all variables in the Table and country
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Discussion
We found that TB is associated with the entire depres-
sion spectrum in the overall sample, and that the associ-
ation between TB and depressive episode is comparable
across regions and country income levels. Furthermore,
the co-occurrence of depression and TB was associated
with a major decrement in all health domains assessed
compared to TB alone, with this additive effect being
particularly pronounced for difficulties in self-care. The
strengths of the study include the large sample size and
use of predominantly nationally representative data from
approximately one-fourth of the countries in the world
obtained by standardized questionnaires across all
countries. To the best of our knowledge, this is the first
general population study on TB and depression. Further-
more, it is one of the very few studies assessing the asso-
ciation between TB and depression severity, and is the
first to assess the joint effect of TB and depression on a
variety of health conditions (i.e., mobility, self-care, pain/
discomfort, cognition, interpersonal activities, sleep/energy).
The finding that there may be a synergistic effect between
TB and depression in terms of some health outcomes (i.e.,
self-care) is novel.
The association between TB and depression may be
bidirectional [7, 25]. Depression itself may compromise
immunity, leading to an increased risk for TB [8], while
increased inflammation in TB may increase risk for
depression [26]. Alternatively, depression may be a psy-
chological reaction to the symptoms of TB (e.g., chronic
cough, fatigue, weight loss) or associated disability [27],
while hypoxia in chronic pulmonary diseases may induce
depression [28]. It is also possible that patients with TB
are perceived as a source of contagion in the commu-
nity, which may lead to discrimination, stigma, social
isolation, and rejection, and may predispose individuals
to a higher risk for depression [27, 29]. Further, some
anti-TB drugs can induce depression [27]. Finally, common
risk factors, such as compromised immunity, stress, and
malnutrition, may underlie the association [8, 26, 30, 31].
Regardless of whether depression and TB are etiologically
related, the mere co-existence can complicate the diagnosis
and management of these conditions, while it is also pos-
sible that they mutually influence each other and lead to the
exacerbation of the other, altering the clinical course [27].
Other factors which were identified as significant
correlates of a depressive episode in our study included
sociodemographic factors (older age, female sex, lower
levels of wealth), smoking, and diabetes. Previous studies
have also found these factors to be associated with
depression [32–36]. In particular, diabetes is known to
increase risk for TB [37], and may be an important risk
factor for TB in LMICs [10] as there is an upward trend
in diabetes prevalence mainly driven by changes in
lifestyles and diet in this setting [38]. On the other hand,
diabetes and depression are often comorbid and com-
mon pathophysiological mechanisms (e.g., stress,
inflammation) may underlie this co-occurrence [39].
In our study, compared to TB occurring in isolation,
co-existing TB/depression was associated with decre-
ments in all health domains assessed, while a significant
interaction was observed for difficulties in self-care.
These results are in line with a small cross-sectional
study from Turkey showing that psychiatric comorbidity
is associated with a higher rate of disability among TB
patients [40]. Depression may lead to poor adherence to
Table 3 Association between tuberculosis (exposure) and
depressive episode (outcome) by regions or country
income level
Region or country income level OR (95% CI) P value
Africa 3.50 (2.76–4.43) <0.0001
Americas 2.74 (1.80–4.18) <0.0001
Asia 3.75 (2.74–5.14) <0.0001
Europe 2.67 (0.75–9.52) 0.1293
Low-income countries 3.52 (2.74–4.54) <0.0001
Middle-income countries 3.24 (2.40–4.35) <0.0001
Estimates are based on multivariable logistic regression
Models are adjusted for age, sex, education, wealth, household size, location,
smoking, alcohol consumption, body mass index, diabetes, and country
OR odds ratio, CI confidence interval
Table 4 Association between TB/depressive episode groups and health status estimated by multivariable linear regression
TB (-) Depression (+) TB (+) Depression (-) TB (+) Depression (+)
b-coefficient (95% CI) P value b-coefficient (95% CI) P value b-coefficient (95% CI) P value
Mobility 15.92 (14.81–17.04) <0.0001 8.63 (6.55–10.71) <0.0001 27.80 (23.60–31.99) <0.0001
Self-care 11.96 (10.78–13.13) <0.0001 5.34 (3.20–7.48) <0.0001 23.80 (19.11–28.49) <0.0001
Pain/discomfort 18.70 (17.39–20.00) <0.0001 10.27 (8.24–12.30) <0.0001 30.41 (26.97–33.84) <0.0001
Cognition 16.55 (15.26–17.83) <0.0001 8.63 (6.35–10.91) <0.0001 24.24 (20.19–28.28) <0.0001
Interpersonal activities 12.69 (11.53–13.86) <0.0001 4.41 (2.34–6.48) <0.0001 19.45 (14.81–24.09) <0.0001
Sleep/energy 19.61 (18.37–20.85) <0.0001 10.32 (7.94–12.70) <0.0001 29.99 (25.30–34.68) <0.0001
Reference category is TB (-) Depression (-)
Health status was the outcome and scores ranged from 0 to 100 with higher scores corresponding to worse health status
Models are adjusted for age, sex, education, wealth, household size, location, smoking, alcohol consumption, body mass index, diabetes, and country
TB tuberculosis, CI confidence interval
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anti-TB drugs, and thereby exacerbate the symptoms of
TB and its associated disability. Indeed, a prospective
study from Peru showed that co-occurring TB/depres-
sion leads to lower adherence to TB treatment and
higher mortality when compared to TB without depres-
sion [3]. The fact that a significant interaction was
observed for self-care may imply that there is a synergis-
tic effect between TB and depression. It may be hypoth-
esized, for example, that depression leads to poor TB
treatment adherence and exacerbation of symptoms,
which in turn may lead to a worsening of depression.
However, the precise underlying mechanisms or the rea-
son why an interaction was only observed for self-care is
unclear and warrants further investigation. Finally,
delayed diagnosis of TB in people with depression may
also partly explain our findings. It has been reported that
delayed detection of physical diseases may be common
in individuals with depression [41]. Thus, it may be that,
when individuals with prior depression are diagnosed
with TB, their TB symptoms are more severe compared
to those without prior depression. Lack of motivation or
social support and cognitive impairment, which may
affect decision-making [42], might limit access to health-
care among depressed individuals, leading to delayed
diagnosis and treatment initiation for TB.
Previous studies have shown that treating the psycho-
logical aspects of TB may lead to better clinical outcomes.
For example, a prospective controlled trial in India showed
that psychotherapy during TB treatment leads to higher
adherence, treatment, and cure rates [43]. Furthermore, a
psychological support group intervention for patients with
MDR-TB in Peru showed that such an intervention can
improve treatment adherence and completion [44].
Additionally, the formation of ‘TB clubs’ in Ethiopia
increased treatment completion rates and reduced the
stigma associated with TB [45]. Recently, a randomized
controlled trial in Ethiopia showed that psychological
counseling and educational intervention can substantially
improve treatment adherence rates in TB [46].
A multi-faceted approach is likely to be relevant in
addressing comorbid depression and TB in LMICs. First,
previous studies from LMICs have shown that the treating
doctor is often not aware of co-existing psychiatric morbid-
ity in TB patients [47]. Thus, training of medical profes-
sionals and students on the psychological aspects of TB may
lead to early detection and better management of psychiatric
complications, and ultimately to a better clinical outcome of
TB. Next, a close collaboration between TB and mental
health specialists would be important for the early detection
and treatment of depression in TB. Previous studies have
shown that training of non-mental health specialists in
LMICs may only have a limited impact on depression
detection rates [48]. Thus, screening for depression may be
a cost-effective strategy to improve detection rates of
depression in TB. However, symptoms specific to depression
(e.g., low mood, anhedonia) and symptoms of depression
that overlap with TB (e.g., fatigue) should be distinguished.
Some studies have assessed the validity of depression
screeners such as the Center for Epidemiological Studies
Depression scale or the General Health Questionnaire 12
among TB patients [40, 49]. These studies found that these
screening tools can be used among TB patients to detect de-
pression but that there may be a disease-specific optimal
cut-off. Future studies on the validity and reliability of such
screening tools are warranted, as only scarce data from
limited populations are currently available. Finally, patient
education and community awareness regarding facts and
myths of TB may also be important [50], as discrimination
and stigma can be underlying causes of depression in TB.
Our results should be interpreted in the light of
several limitations. First, we lacked information on HIV,
which is known to be associated with higher risk for TB
[1] and depression [51]. Thus, some of the association
may be attributable to comorbid HIV. However, this
may not have been a major limitation as our region-wise
analysis showed that TB is associated with depression
even in areas with very low HIV prevalence (e.g., the
Americas). Second, our study was based on the symp-
toms of TB rather than a laboratory confirmed diagnosis.
Although we used the identical definition for TB used in
previous publications [10–12], it is possible that some
level of symptom overlap may exist between respiratory
diseases such as pneumonia, bronchitis, and chronic
obstructive pulmonary disease, which may also cause
cough of long duration and hemoptysis. Thus, our
estimates may partially be representing the association
between these conditions and depression. Furthermore, the
potential misclassification may have led to an underestima-
tion of the association between TB and depression. How-
ever, it is reassuring that the prevalence of depression in TB
was within the previously reported range of estimates
among patients with confirmed TB [2]. Additionally, we are
not aware of any other population-based data with such a
large number of LMICs that can be used to investigate the
TB–depression relationship. Third, high-risk groups, such
as the institutionalized and homeless, were not included in
our study and thus our findings are not generalizable to this
population. Finally, the direction of causality cannot be
established due to the cross-sectional design.
Conclusions
In conclusion, individuals with TB have higher odds for
depression, and the co-occurrence of TB and depression
is associated with decrements in health. Screening for and
addressing depression in individuals with TB may lead to
better clinical outcomes. However, mental health services
and specialists are limited in low-resourced settings where
the highest burden of TB is located. Increased recognition
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of co-existing depression in TB patients by health
professionals and the use of non-specialist health workers
trained in mental healthcare, especially in resource-
limited settings, may be key. However, given that health-
care workers are at increased risk of occupationally
acquired TB in LMICs [52], sound infection control mea-
sures should be implemented to protect these individuals,
yet this is a particular challenge in LMICs due to financial
constraints. Finally, simultaneously addressing the mental
and physical aspects of TB may lead to reduction in TB
transmission [53], and also possibly in TB mortality and
MDR-TB. This is an area for future research.
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